Numerous signal transduction pathways, e.g., RAS-RAF and MYC [5,6], are involved in pro-inflammatory and tumour-promoting processes, however, the nuclear factor kappa light-chain enhancer of activated B-cells (NFκB) pathway has a preeminent position in the context of cancer and inflammation. Here, NFKB1 is linked to cancer.